New Technologies at Medtech Startups in July 2011

2 Min Read

Below is the list of technologies at companies identified during the month of July 2011 and added to the Medtech Startups Database.

Below is the list of technologies at companies identified during the month of July 2011 and added to the Medtech Startups Database.

  • Hand-held diagnosis of coronary artery disease.
  • Low field magnetic stimulation for neuromodulation in psychiatric and neurological disorders.
  • Thermal based ablation device
  • Technologies for interventional endoscopic procedures.
  • Stealth medical technology company. Principal has degree in glass science.
  • Cold plasma for accelerating wound healing, and other applications.
  • Tissue guided surgery in unicompartmental knee arthoplasty
  • Minimally invasive surgery of the sinuses via tear duct access.
  • Synthetic materials to support tissue regeneration for wound healing, bone regeneration, cartilage repair, stem cell therapy and dermal fillers.
  • Surgical technologies, including device for use in bariatrics (malabsorption).
  • New dosing technology for insulin in treatment of diabetes.

Updated regularly with addition of 10-20 new companies per month, the Medtech Startups Database currently contains contact details, business/product/technology descriptions and other data with records searchable by keyword and categorized by clinical/technology segment. Currently the database contains approximately 1,000 medical technology startup companies spanning medical device, biotech, biomaterials, diagnostics, pharmaceuticals and other medical product companies. 

     

Share This Article
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Exit mobile version